insights_auto
Why is PACB down 15.44%?
Dive Deeperchevron_right
PACB:NASDAQ
Pacific Biosciences of California Inc
$2.30
arrow_downward
-15.44%(-0.42) 1D
$2.31
arrow_upward
+0.43% (+0.0100)bedtimeAfter hours
Closed: Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PACB...
Open
$2.63
High
$2.69
Low
$2.22
Mkt. cap
714.91M
Avg. vol.
13.52M
Volume
0.00
52-wk high
$3.44
52-wk low
$1.07
EPS
-$0.43
Beta
2.19
Shares outstanding
310.83M
No. of employees
485
Open
$2.63
High
$2.69
Low
$2.22
Mkt. cap
714.91M
Avg. vol.
13.52M
Volume
0.00
52-wk high
$3.44
52-wk low
$1.07
EPS
-$0.43
Beta
2.19
Shares outstanding
310.83M
No. of employees
485
News stories
From web sources and news partners
Yahoo Finance
·
5 hours ago
PacBio (PACB) Stock Gets Fair Value Boost After UBS Starts Coverage Neutral
Yahoo Finance UK
·
8 hours ago
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today
www.marketscreener.com
·
9 hours ago
Pacific Biosciences of California Insider Sold Shares Worth $2,056,921, According to a Recent SEC Filing
Profile
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
About Pacific Biosciences of California Inc
CEOChristian Henry
Employees485
Founded2004
HeadquartersMenlo Park, California, United States
SectorHealth care
Websitepacb.com